A novel coronavirus associated with severe acute respiratory syndrome.

By T. Ksiazek, D. Erdman, C. Goldsmith, S. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim and 16 more. New England Journal of Medicine, 2003

4,257 citations recorded by the source corpus.

Subfields: Infectious Diseases, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/67706ca37b76a8e1c51fccf1793454e9a9d9427d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. P. Masters
2. Ralph S. Baric
3. Fang Li
4. S. Perlman
5. D. Veesler
6. S. Weiss
7. A. Walls
8. Rachel L. Graham

In Pulmonary and Respiratory Medicine

1. Yi-Wei Tang
2. Arthur S Slutsky

Citations in the corpus

• Coronavirus Pathogenesis (2011, background): “Electron microscopy, virus isolation, cloning, and sequencing studies demonstrated that a novel coronavirus was the etiologic agent of SARS (Drosten et al., 2003; Ksiazek et al., 2003; Marra et al., 2003; Peiris et al., 2003b; Rota et al., 2003).”
• Network theory and SARS: predicting outbreak diversity (2004, background): “More than two years since the first case of severe acute respiratory syndrome (SARS), a respiratory illness caused by a novel coronavirus, occurred in Guangdong province of China (November, 2002) and more than 18 months since the syndrome was first recognized outside of Asia (in Canada on March 13, ”
• ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia (2005, background): “An intense, cooperative worldwide effort rapidly led to the identification of the diseasecausing agent as a novel SARS coronavirus (CoV) (18, 32) and the subsequent complete sequencing of the viral genome (24, 37).”
• Laboratory diagnosis of emerging human coronavirus infections – the state of the art (2020, background): “SARS-CoV and MERS-CoV and SARS-CoV-2 will grow in primary monkey cells and cell lines such as Vero and LLC-MK2, but cell culture should not be performed for suspect cases in routine diagnostic laboratories for biosafety reasons [2, 6, 31, 32] .”
• A decade after SARS: Strategies to control emerging coronaviruses (2013, background): “Radiological examination of SARS-CoV-and MERS-CoV-infected patients reveals atypical pneumonia 42, 128, 129, 140 .”
• Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003, background): “The most prominent pathological findings in lung tissue samples on autopsy have been diffuse alveolar damage with hyaline membrane formation, interstitial mononuclear infiltration, and desquamation of pneumocytes; in some cases, tissues have shown intraalveolar hemorrhage, necrotic debris within sma”
• Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection (2007, background): “During the epidemic in 2003, 8,096 cases with 774 deaths had occurred in over 30 countries among five continents (89, 117, 144, 180, 182, 197, 236, 250, 259, 260, 270, 290, 292, 303, 336, 377).”
• Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis (2020, background): “Crude surveillance data [42], indicated that till March 14, 2020, from 156,106 reported cases, 5,829 patients have died (3.73%), with> 52% of the deaths occurring in China (3,085), followed by Italy with 24.72% (1,441).”